Willem K. Smits
Utrecht, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Elevated enhancer-oncogene contacts and higher oncogene expression levels by recurrent CTCF inactivating mutations in acute T cell leukemia.
Journal: Cell reports
Published: October 25, 2022
STAT5 does not drive steroid resistance in T-cell acute lymphoblastic leukemia despite the activation of BCL2 and BCLXL following glucocorticoid treatment.
Journal: Haematologica
Published: November 23, 2021
MEF2C opposes Notch in lymphoid lineage decision and drives leukemia in the thymus.
Journal: JCI insight
Published: April 21, 2021
Recurrent NR3C1 Aberrations at First Diagnosis Relate to Steroid Resistance in Pediatric T-Cell Acute Lymphoblastic Leukemia Patients.
Journal: HemaSphere
Published: July 01, 2020
Deletion 6q Drives T-cell Leukemia Progression by Ribosome Modulation.
Journal: Cancer discovery
Published: July 30, 2017
Lentiviral gene transfer into human and murine hematopoietic stem cells: size matters.
Journal: BMC research notes
Published: February 19, 2016
Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptors.
Journal: Haematologica
Published: August 27, 2013
Last Updated: 09/26/2026